Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v22-EN Version v21-FR
Language English French
Date Updated 2023-01-12 2023-01-11
Drug Identification Number 02230302 02230302
Brand name CODEINE CONTIN 50MG CONTROLLED RELEASE TAB CODEINE CONTIN 50MG CONTROLLED RELEASE TAB
Common or Proper name Codeine Controlled Release Tablets Codeine Controlled Release Tablets
Company Name PURDUE PHARMA PURDUE PHARMA
Ingredients CODEINE CODEINE
Strength(s) 50MG 50MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code R05DA R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-10-27 2022-10-27
Actual start date 2022-10-27 2022-10-27
Estimated end date 2023-01-13 2023-01-13
Actual end date 2023-01-11 2023-01-11
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments